Kenedix Office Investment Corp
TSE:8972
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
141 700
168 400
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Kenedix Office Investment Corp
Current Assets | 64.8B |
Cash & Short-Term Investments | 32.1B |
Receivables | 685.6m |
Other Current Assets | 32B |
Non-Current Assets | 1.2T |
Long-Term Investments | 1.1T |
PP&E | 46.9B |
Intangibles | 7.7B |
Other Non-Current Assets | 7.2B |
Current Liabilities | 83.6B |
Accounts Payable | 2.4B |
Accrued Liabilities | 469.9m |
Short-Term Debt | 8.9B |
Other Current Liabilities | 71.8B |
Non-Current Liabilities | 514.9B |
Long-Term Debt | 470.2B |
Other Non-Current Liabilities | 44.7B |
Balance Sheet
Kenedix Office Investment Corp
Oct-2014 | Oct-2015 | Oct-2016 | Oct-2017 | Oct-2018 | Oct-2019 | Oct-2020 | Oct-2021 | Oct-2022 | Oct-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
6 619
|
13 557
|
11 268
|
19 917
|
14 051
|
14 019
|
16 129
|
19 274
|
20 376
|
28 937
|
|
Cash Equivalents |
6 619
|
13 557
|
11 268
|
19 917
|
14 051
|
14 019
|
16 129
|
19 274
|
20 376
|
28 937
|
|
Total Receivables |
293
|
338
|
331
|
315
|
360
|
361
|
336
|
286
|
396
|
378
|
|
Accounts Receivables |
293
|
338
|
331
|
315
|
360
|
361
|
336
|
286
|
396
|
378
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
11 005
|
9 128
|
9 558
|
10 026
|
11 100
|
11 551
|
12 166
|
11 552
|
11 871
|
11 854
|
|
Total Current Assets |
17 918
|
23 023
|
21 157
|
30 258
|
25 511
|
25 932
|
28 631
|
31 112
|
32 644
|
41 168
|
|
PP&E Net |
52 493
|
52 608
|
52 689
|
43 862
|
41 237
|
40 754
|
40 406
|
40 083
|
43 116
|
39 419
|
|
PP&E Gross |
52 493
|
52 608
|
52 689
|
43 862
|
41 237
|
40 754
|
40 406
|
40 083
|
43 116
|
39 419
|
|
Accumulated Depreciation |
4 537
|
5 070
|
5 855
|
6 192
|
6 622
|
7 325
|
8 114
|
8 871
|
9 708
|
9 565
|
|
Intangible Assets |
355
|
353
|
357
|
642
|
640
|
637
|
634
|
632
|
631
|
629
|
|
Long-Term Investments |
315 667
|
329 605
|
337 250
|
338 677
|
368 246
|
371 002
|
388 645
|
383 175
|
394 588
|
391 513
|
|
Other Long-Term Assets |
1 738
|
1 627
|
1 579
|
1 494
|
1 588
|
1 448
|
1 404
|
1 325
|
2 035
|
2 639
|
|
Total Assets |
388 170
N/A
|
407 217
+5%
|
413 032
+1%
|
414 934
+0%
|
437 221
+5%
|
439 773
+1%
|
459 720
+5%
|
456 328
-1%
|
473 013
+4%
|
475 368
+0%
|
|
Liabilities | |||||||||||
Accounts Payable |
743
|
1 104
|
1 367
|
1 231
|
1 342
|
1 120
|
1 497
|
1 643
|
1 737
|
2 092
|
|
Accrued Liabilities |
133
|
497
|
420
|
221
|
257
|
202
|
384
|
356
|
411
|
397
|
|
Short-Term Debt |
15 900
|
2 500
|
1 500
|
6 000
|
6 000
|
2 200
|
12 500
|
10 600
|
300
|
2 000
|
|
Current Portion of Long-Term Debt |
30 135
|
30 800
|
25 700
|
20 050
|
13 750
|
21 600
|
23 000
|
19 550
|
14 300
|
29 600
|
|
Other Current Liabilities |
2 142
|
2 274
|
2 398
|
2 561
|
3 143
|
3 058
|
3 363
|
3 071
|
3 339
|
3 451
|
|
Total Current Liabilities |
49 054
|
37 176
|
31 384
|
30 063
|
24 491
|
28 180
|
40 743
|
35 220
|
20 087
|
37 540
|
|
Long-Term Debt |
141 650
|
140 800
|
150 900
|
153 550
|
163 300
|
161 250
|
166 250
|
168 600
|
200 350
|
183 350
|
|
Other Liabilities |
16 621
|
17 327
|
17 923
|
18 469
|
20 116
|
21 067
|
22 061
|
21 963
|
23 014
|
22 955
|
|
Total Liabilities |
207 325
N/A
|
195 303
-6%
|
200 206
+3%
|
202 082
+1%
|
207 907
+3%
|
210 497
+1%
|
229 055
+9%
|
225 783
-1%
|
243 451
+8%
|
243 844
+0%
|
|
Equity | |||||||||||
Common Stock |
176 633
|
206 200
|
206 200
|
206 200
|
220 971
|
220 971
|
220 971
|
220 971
|
217 971
|
217 971
|
|
Retained Earnings |
4 212
|
5 715
|
6 626
|
6 614
|
8 242
|
8 620
|
10 086
|
9 828
|
10 777
|
11 920
|
|
Other Equity |
0
|
0
|
1
|
38
|
101
|
314
|
391
|
253
|
814
|
1 632
|
|
Total Equity |
180 845
N/A
|
211 915
+17%
|
212 825
+0%
|
212 851
+0%
|
229 314
+8%
|
229 276
0%
|
230 665
+1%
|
230 545
0%
|
229 562
0%
|
231 523
+1%
|
|
Total Liabilities & Equity |
388 170
N/A
|
407 217
+5%
|
413 032
+1%
|
414 934
+0%
|
437 221
+5%
|
439 773
+1%
|
459 720
+5%
|
456 328
-1%
|
473 013
+4%
|
475 368
+0%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|